Elixir Pharmaceuticals to Present at Biotechnology Industry Organization (BIO) CEO & Investor Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Elixir Pharmaceuticals, Inc., announced today its President and Chief Executive Officer William K. Heiden is scheduled to present at the 10th Annual BIO CEO and Investor Conference in New York on Wednesday, February 13, 2008, at 2:00 p.m. ET in the Park Avenue Suite. The conference takes place at the Waldorf-Astoria Hotel in New York City.

Back to news